View Single Post
Old 11-22-2010, 11:08 AM   #7
Lee Sam
Member
 
Location: Ann Arbor, MI

Join Date: Oct 2008
Posts: 57
Default

Quote:
Originally Posted by polytoo View Post
As of this week we have completed over 1,500 ChIP-Seq samples on the Helicos. A few nanograms, no library creation, just a little poly A tailing and zoom, 9-14 million reads on 46 samples every 14 days (we like to relax before we fill it up again.).

Just don't ask me why they just got delisted on NASDAQ and are trading at 22 cents. I have no idea. ;-( Keith Robison spells it out pretty well in the other thread. Their marketing should have been something like "It's all about the message" and focused on ChIP-Seq, RNA-Seq, DGE and all of the above from paraffin, nanogram amounts, no amplification, no bias.

They should have never chased after the human genome. Wrong tool for the job.

-Paul Morrison
They got delisted because their stock price didn't have a price level over $1 per NASDAQ rules.

I have experience with Helicos mRNA-Seq (having just submitted a paper using the technology).
Lee Sam is offline   Reply With Quote